Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 18 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
171 27.3 months Castration-resistant prostate cancer 4 Chemotherapy
University of Siena Italy 2/2011
Treatment Details: Patients: This study involved male patients with advanced castration-resistant prostate cancer that were divided into two separate treatment groups. Group A included 37 patients with a med
 
172 27.3 months metastatic breast cancer 4 Chemotherapy
Azienda Ospedaliera San Luigi Italy 2/2005
Treatment Details: Patients: This study involved 61 women with metastatic breast cancer. The median age was 54.3 years. All patients had received previous anthracycline chemotherapy and all except one had re
 
173 27.3 months Metastatic Breast Cancer 5 Biologic therapy
Chemotherapy
University of Alberta Canada 1/2015
Treatment Details: Patients: This phase 3 study involved female metastatic breast cancer patients who were divided into two separate treatment groups. Group A had 759 patients with a median age of 54 years,
 
174 27.3 months Metastatic Breast Cancer 5 Biologic therapy
Chemotherapy
Hospital Universitario de Valme Spain 8/2014
Treatment Details: Patients: This phase 2 study involved 90 metastatic breast cancer patients. The median patient age was 52 years and 99% were female. Treatment: Patients received chemotherapy with pacl
 
175 27.2 months Metastatic Breast Cancer 5 Chemotherapy
University of Alberta Canada 1/2015
Treatment Details: Patients: This phase 3 study involved female metastatic breast cancer patients who were divided into two separate treatment groups. Group A had 759 patients with a median age of 54 years,
 
176 27.2 months Metastatic colorectal cancer 4 Chemotherapy
Hallym University Sacred Heart Hospital Korea 1/2009
Treatment Details: Patients: This study involved 48 metastatic colorectal cancer patients. The median age of the group was 56 years (range of 24-70) and 52% were male. Treatment: Patients were given two
 
177 27.1 months Castration-resistant prostate cancer 4 Chemotherapy
Kyoto University Graduate School of Medicine Japan 7/2012
Treatment Details: Patients: This study involved 29 men with castration-resistant prostate cancer who had a median age of 72 years. Treatment: Patients were treated with a reduced dose of the chemotherapy
 
178 27.0 months Peripheral T-cell lymphoma 5 Biologic therapy
Chemotherapy
Hormone
University Medical Center Groningen, University of Groningen Netherlands 7/2011
Treatment Details: Patients: This phase 2 study involved 20 peripheral T-cell lymphoma patients. The median patient age was 50 years and 11 were male. Treatment: Patients were treated with the chemothera
 
179 27.0 months T-cell lymphoma 5 Chemotherapy
Hormone
Immunotherapy
University Medical Center Groningen Netherlands 7/2011
Treatment Details: Patients: This study involved 20 patients with T-cell lymphoma. The median patient age was 50 years and 11 were males. Treatment: Patients were treated with the chemotherapy agents cyc
 
180 27.0 months Castration-resistant prostate cancer 5 Biologic therapy
Chemotherapy
Cancer Center Poland 3/2014
Treatment Details: Patients: This phase 2 study involved castration-resistant prostate cancer patients who were divided into two separate treatment groups. Group A consisted of 98 patients with a median age
 
Page 18 of 187  | Previous Page  | Next Page